The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: A longitudinal 10-year follow-up study

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 3, 2013, Pages 323-331

  Ford, A C ^a,b   Forman, D ^b,c   Bailey, A G ^a   Axon, A T R ^a   Moayyedi, P ^d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CAUSE OF DEATH; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL; SYMPTOM;

BODY MASS INDEX; ENGLAND; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; SURVIVAL RATE; TIME FACTORS;

EID: 84871950531     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12169     Document Type: Article

References (37)

1. Chiocca JC, Olmos JA, Salis GB, et al,. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther 2005; 22: 331-42. (Pubitemid 41207463)
2. Cho Y-S, Choi M-G, Jeong J-J, et al,. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si. Korea. Am J Gastroenterol 2005; 100: 747-53. (Pubitemid 40592361)
3. Locke GR III, Talley NJ, Fett SL, et al,. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County. Minnesota. Gastroenterology 1997; 112: 1448-56. (Pubitemid 27181367)
4. Wong WM, Lai KC, Lam KF, et al,. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2004; 18: 595-604. (Pubitemid 37186609)
5. Kennedy T, Jones R,. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589-94. (Pubitemid 32011732)
6. Mahadeva S, Raman MC, Ford AC, et al,. Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia. Aliment Pharmacol Ther 2005; 21: 1483-90. (Pubitemid 40874166)
7. Dent J, El-Serag HB, Wallander M-A, et al,. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-7. (Pubitemid 40559260)
8. Kulig M, Leodolter A, Vieth M, et al,. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767-76. (Pubitemid 37323641)
9. Ronkainen J, Aro P, Storskrubb T, et al,. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population-the Kalixanda study. Aliment Pharmacol Ther 2006; 23: 1725-33. (Pubitemid 43846416)
10. Ronkainen J, Aro P, Storskrubb T, et al,. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-85. (Pubitemid 40476458)
11. Ronkainen J, Talley NJ, Storskrubb T, et al,. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011; 106: 1946-52.
12. Lagergren J, Bergstrom R, Lindgren A, et al,. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31. (Pubitemid 29142625)
13. Agreus L, Svardsudd K, Talley NJ, et al,. Natural history of gastroesophageal reflux disease and functional abdominal disorders. Am J Gastroenterol 2001; 96: 2905-14. (Pubitemid 32959532)
14. Hansen JM, Wildner-Christensen M, Schaffalitzky de Muckadell OB,. Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care use. Am J Gastroenterol 2009; 104: 2394-403.
15. Ness-Jensen E, Lindam A, Lagergren J, et al,. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut 2012; 61: 1390-7.
16. Ford AC, Forman D, Bailey AG, et al,. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007; 56: 321-7. (Pubitemid 46579758)
17. Ford AC, Forman D, Bailey AG, et al,. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008; 103: 1229-39. (Pubitemid 351677964)
18. Ford AC, Forman D, Bailey AG, et al,. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther 2008; 28: 1013-20.
19. Ford AC, Forman D, Bailey AG, et al,. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study. Am J Gastroenterol 2007; 102: 957-65. (Pubitemid 46698219)
20. Ford AC, Forman D, Bailey AG, et al,. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am J Gastroenterol 2012; 107: 912-21.
21. Moayyedi P, Feltbower R, Brown J, et al,. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665-9. (Pubitemid 30248477)
22. Moayyedi P, Duffett S, Braunholtz D, et al,. The Leeds dyspepsia questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998; 12: 1257-62. (Pubitemid 28565967)
23. Manning AP, Thompson WG, Heaton KW, et al,. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 277: 653-4. (Pubitemid 9004104)
24. Dupuy HJ,. The Psychological General Well-Being (PGWB) Index. In:, Fruberg CF, Wenger NK, Mattson ME, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Publishing Inc, 1984; 170-83.
25. Glise H, Hallerback B, Johansson B,. Quality of Life assessments in the evaluation of gastroesophageal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol 1995; 208: 131-5.
26. Fraser A, Delaney BC, Ford AC, et al,. The short-form Leeds dyspepsia questionnaire validation study. Aliment Pharmacol Ther 2007; 25: 477-86. (Pubitemid 46184462)
27. Halder SLS, Locke GR, Talley NJ, et al,. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004; 19: 233-42. (Pubitemid 38174892)
28. Mahadeva S, Yadav H, Rampal S, et al,. Risk factors associated with dyspepsia in a rural Asian population and its impact on quality of life. Am J Gastroenterol 2010; 105: 904-12.
29. Longstreth GF, Thompson WG, Chey WD, et al,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
30. Ford AC, Talley NJ, Veldhuyzen Van Zanten SJ, et al,. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008; 300: 1793-805.
31. Hampel H, Abraham NS, El-Serag HB,. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211. (Pubitemid 41076753)
32. Jones R, Lydeard S,. Irritable bowel syndrome in the general population. Br Med J 1992; 304: 87-90.
33. Kennedy TM, Jones RH, Hungin APS, et al,. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998; 43: 770-4. (Pubitemid 28539655)
34. Locke GR III, Zinsmeister AR, Talley NJ, et al,. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000; 75: 907-12.
35. El-Serag H, Hill C, Jones R,. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK general practice research database. Aliment Pharmacol Ther 2009; 29: 470-80.
36. Talley NJ, Locke GR III, McNally M, et al,. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol 2008; 103: 12-9.
37. Becher A, El-Serag HB,. Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review. Scand J Gastroenterol 2008; 43: 645-53. (Pubitemid 351868718)